GC Wellbeing showcases Rebornne acellular dermal matrix skin booster in Tokyo

GC Wellbeing presented its extracellular matrix skin booster, Rebornne, at the Aesthetic Surgery and Laser Society conference in Tokyo on June 28, 2026. The product, which is based on human acellular dermal matrix, was featured alongside the company's Giselle PDRN 2.5 and 2.0 lines in partnership with Japanese distributor Nifuji. During the event, which drew 500 medical professionals and 30 aesthetic companies, Lumi Clinic director Yoo Kyung-hoon delivered a lecture detailing clinical applications for acellular dermal matrix therapy.

For clinical business owners, this indicates a clear shift toward structural regenerative agents that go beyond simple hydration. While traditional PDRN products focus on cellular signaling, acellular dermal matrix boosters like Rebornne physically replenish the extracellular matrix scaffold. This category is gaining rapid traction in Asian markets, particularly among Japanese clinicians. If your patient demographic actively tracks overseas skincare trends, expect inquiries to move from basic polynucleotides to these more complex, matrix-based structural boosters. Keeping an eye on how these products navigate regulatory pathways outside of Asia will help you time your own portfolio expansion.

Source: BusinessKorea, https://www.businesskorea.co.kr/news/articleView.html?idxno=218335